Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 3/20 | 0.43 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.39 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.39 |
| ▸ | NR1I3 | Q14994 | 3/20 | 0.38 |
| ▸ | SREBF2 | Q12772 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19503080 | 0.84 | PPARG (0.55) | CA12CA1CA9PPARGCYP17A1 | |
| SCHEMBL12065312 | 0.82 | PPARG (0.46) | CA12CA1CA9PPARGCYP17A1 | |
| SCHEMBL27437719 | 0.81 | CA12 (0.43) | CA12CA1CA9PPARGCYP17A1 | |
| SCHEMBL6096016 | 0.79 | CA12 (0.41) | CA12CA1CA9PPARGCYP17A1 | |
| SCHEMBL29055932 | 0.78 | ALDH1A1 (0.45) | CA12CA1CA9PPARGCYP17A1 | |
| SCHEMBL27474162 | 0.77 | PPARG (0.56) | PPARGCYP17A1ALDH1A1GAAPPARA | |
| SCHEMBL25312191 | 0.77 | ALOX15 (0.44) | PPARGALDH1A1GAAPPARAALOX15 | |
| SCHEMBL6384397 | 0.77 | SMN1; SMN2 (0.48) | PPARGALDH1A1GAA | |
| SCHEMBL29096931 | 0.76 | TOP2A (0.50) | PPARGALDH1A1GAAPPARAALOX15 | |
| SCHEMBL17903007 | 0.76 | CA12 (0.55) | CA12CA1CA9CYP17A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2576495-B1 | NOVEL DERIVATIVES OF MESALAZINE, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF INTESTINAL INFLAMMATORY DISEASES | SOFAR SPA (IT) | 2017-10-25 | — | — | EP | disclosed |